Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells

Toxicology in Vitro

Volumn 26, Issue 5, 2012, Pages 709-717

  Huc, Laurence ^a   Lemarié, Anthony ^b,c   Guéraud, Françoise ^a   Héliès Toussaint, Cécile ^a  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Bisphenol A; Cytometry; Hepatic cells; Lipids; Mitochondrial reactive oxygen species; Steatosis

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; FAT DROPLET; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY TEST; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HUMAN CELL; HYPERPOLARIZATION; IN VITRO STUDY; LIPID PEROXIDATION; LIPID STORAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS;

ALDEHYDES; ENDOCRINE DISRUPTORS; HEP G2 CELLS; HUMANS; INTERLEUKIN-8; LIPID METABOLISM; LIPID PEROXIDATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NITRIC OXIDE; PHENOLS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861526983     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.03.017     Document Type: Article

References (61)

1. Alonso-Magdalena P., Ropero A.B., Carrera M.P., Cederroth C.R., Baquie M., Gauthier B.R., Nef S., Stefani E., Nadal A. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 2008, 3:e2069.
2. Andersen H.R., Andersson A.M., Arnold S.F., Autrup H., Barfoed M., Beresford N.A., Bjerregaard P., Christiansen L.B., Gissel B., Hummel R., Jorgensen E.B., Korsgaard B., Le Guevel R., Leffers H., McLachlan J., Moller A., Nielsen J.B., Olea N., Oles-Karasko A., Pakdel F., Pedersen K.L., Perez P., Skakkeboek N.E., Sonnenschein C., Soto A.M., et al. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ. Health Perspect. 1999, 107(Suppl. 1):89-108.
3. Audebert M., Dolo L., Perdu E., Cravedi J.P., Zalko D. Use of the gamma H2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch. Toxicol. 2011, 85(11):1463-1473.
4. Begriche K., Igoudjil A., Pessayre D., Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006, 6:1-28.
5. Ben-Jonathan N., Hugo E.R., Brandebourg T.D. Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol. Cell. Endocrinol. 2009, 304:49-54.
6. Bindhumol V., Chitra K.C., Mathur P.P. Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 2003, 188:117-124.
7. Borovic S., Rabuzin F., Waeg G., Zarkovic N. Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates. Free Radic. Res. 2006, 40:809-820.
8. Bouskine A., Nebout M., Brucker-Davis F., Benahmed M., Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ. Health Perspect. 2009, 117:1053-1058.
9. Brown G.C. Nitric oxide and mitochondria. Front. Biosci. 2007, 12:1024-1033.
10. Bursztyka J., Perdu E., Pettersson K., Pongratz I., Fernandez-Cabrera M., Olea N., Debrauwer L., Zalko D., Cravedi J.P. Biotransformation of genistein and bisphenol A in cell lines used for screening endocrine disruptors. Toxicol. In Vitro 2008, 22:1595-1604.
11. Chen J., Schenker S., Frosto T.A., Henderson G.I. Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits. Biochim. Biophys. Acta 1998, 1380:336-344.
12. Chiappini F., Barrier A., Saffroy R., Domart M.C., Dagues N., Azoulay D., Sebagh M., Franc B., Chevalier S., Debuire B., Dudoit S., Lemoine A. Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab. Invest. 2006, 86:154-165.
13. Cytobank software. Available from: http://www.cytobank.org.
14. Day C.P. From fat to inflammation. Gastroenterology 2006, 130:207-210.
15. Donato M.T., Martinez-Romero A., Jimenez N., Negro A., Herrera G., Castell J.V., O'Connor J.E., Gomez-Lechon M.J. Cytometric analysis for drug-induced steatosis in HepG2 cells. Chem. Biol. Interact. 2009, 181:417-423.
16. Dowman J.K., Tomlinson J.W., Newsome P.N. Pathogenesis of non-alcoholic fatty liver disease. QJM 2011, 103:71-83.
17. Endo M., Masaki T., Seike M., Yoshimatsu H. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp. Biol. Med. (Maywood) 2007, 232:614-621.
18. Feldstein A.E., Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F., Rydzewski R., Burgart L.J., Gores G.J. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004, 40:185-194.
19. Fernandez M.F., Arrebola J.P., Taoufiki J., Navalon A., Ballesteros O., Pulgar R., Vilchez J.L., Olea N. Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod. Toxicol. 2007, 24:259-264.
20. Grun F., Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006, 147:S50-S55.
21. Gueraud F., Atalay M., Bresgen N., Cipak A., Eckl P.M., Huc L., Jouanin I., Siems W., Uchida K. Chemistry and biochemistry of lipid peroxidation products. Free Radici Res. 2010, 44:1098-1124.
22. Hanson M.A., Gluckman P.D. Developmental origins of health and disease: new insights. Basic Clin. Pharmacol. Toxicol. 2008, 102:90-93.
23. Hruszkewycz A.M. Evidence for mitochondrial DNA damage by lipid peroxidation. Biochem. Biophys. Res. Commun. 1988, 153:191-197.
24. Huc L., Sparfel L., Rissel M., Dimanche-Boitrel M.T., Guillouzo A., Fardel O., Lagadic-Gossmann D. Identification of Na+/H+ exchange as a new target for toxic polycyclic aromatic hydrocarbons. FASEB J. 2004, 18:344-346.
25. Hugo E.R., Brandebourg T.D., Woo J.G., Loftus J., Alexander J.W., Ben-Jonathan N. Bisphenol a at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 2008, 116:1642-1647.
26. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 2002, 17:2839-2841.
27. Jarrar M.H., Baranova A., Collantes R., Ranard B., Stepanova M., Bennett C., Fang Y., Elariny H., Goodman Z., Chandhoke V., Younossi Z.M. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2008, 27:412-421.
28. Joshi-Barve S., Barve S.S., Amancherla K., Gobejishvili L., Hill D., Cave M., Hote P., McClain C.J. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 2007, 46:823-830.
29. Kovacic P. How safe is bisphenol A? Fundamentals of toxicity: metabolism, electron transfer and oxidative stress. Med. Hypotheses 2010, 75:1-4.
30. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
31. Lapensee E.W., Tuttle T.R., Fox S.R., Ben-Jonathan N. Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells. Environ. Health Perspect. 2009, 117:175-180.
32. Lawson J.A., Fisher M.A., Simmons C.A., Farhood A., Jaeschke H. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology 1998, 28:761-767.
33. Lee S., Suk K., Kim I.K., Jang I.S., Park J.W., Johnson V.J., Kwon T.K., Choi B.J., Kim S.H. Signaling pathways of bisphenol A-induced apoptosis in hippocampal neuronal cells: role of calcium-induced reactive oxygen species, mitogen-activated protein kinases, and nuclear factor-kappaB. J. Neurosci. Res. 2008, 86:2932-2942.
34. Legler J., Hamers T., van Eck van der Sluijs-van de Bor M., Schoeters G., van der Ven L., Eggesbo M., Koppe J., Feinberg M., Trnovec T. The OBELIX project: early life exposure to endocrine disruptors and obesity. Am. J. Clin. Nutr. 2011, 94(Suppl. 6):1933S-1938S.
35. Machida K., Tanaka T. Farnesol-induced generation of reactive oxygen species dependent on mitochondrial transmembrane potential hyperpolarization mediated by F(0)F(1)-ATPase in yeast. FEBS Lett. 1999, 462:108-112.
36. Marmugi A., Ducheix S., Lasserre F., Polizzi A., Paris A., Priymenko N., Bertrand-Michel J., Pineau T., Guillou H., Martin P.G., Mselli-Lakhal L. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012, 55:395-407.
37. Masuno H., Iwanami J., Kidani T., Sakayama K., Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol. Sci. 2005, 84:319-327.
38. Migliarini B., Piccinetti C.C., Martella A., Maradonna F., Gioacchini G., Carnevali O. Perspectives on endocrine disruptor effects on metabolic sensors. Gen. Comp. Endocrinol. 2011, 170:416-423.
39. Myers J.P., Zoeller R.T., vom Saal F.S. A clash of old and new scientific concepts in toxicity, with important implications for public health. Environ. Health Perspect. 2009, 117:1652-1655.
40. Nakagawa Y., Tayama S. Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes. Arch. Toxicol. 2000, 74:99-105.
41. Noguchi S., Nakatsuka M., Asagiri K., Habara T., Takata M., Konishi H., Kudo T. Bisphenol A stimulates NO synthesis through a non-genomic estrogen receptor-mediated mechanism in mouse endothelial cells. Toxicol. Lett. 2002, 135:95-101.
42. Ooe H., Taira T., Iguchi-Ariga S.M., Ariga H. Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. Toxicol. Sci. 2005, 88:114-126.
43. Pagano C., Soardo G., Esposito W., Fallo F., Basan L., Donnini D., Federspil G., Sechi L.A., Vettor R. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur. J. Endocrinol. 2005, 152:113-118.
44. Pessayre D., Fromenty B. NASH: a mitochondrial disease. J. Hepatol. 2005, 42:928-940.
45. Rubin B.S., Soto A.M. Bisphenol A: perinatal exposure and body weight. Mol. Cell. Endocrinol. 2009, 304:55-62.
46. Rubin B.S., Murray M.K., Damassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 2001, 109:675-680.
47. Sajiki J., Takahashi K., Yonekubo J. Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography. J. Chromatogr. B: Biomed. Sci. Appl. 1999, 736:255-261.
48. Schonfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 2002, 110:A703-A707.
49. Serviddio G., Sastre J., Bellanti F., Vina J., Vendemiale G., Altomare E. Mitochondrial involvement in non-alcoholic steatohepatitis. Mol. Aspects Med. 2008, 29:22-35.
50. Swedenborg E., Ruegg J., Makela S., Pongratz I. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J. Mol. Endocrinol. 2009, 43:1-10.
51. Takeuchi T., Tsutsumi O. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem. Biophys. Res. Commun. 2002, 291:76-78.
52. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 2009, 30:75-95.
53. vom Saal F.S., Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect. 2005, 113:926-933.
54. vom Saal F.S., Welshons W.V. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ. Res. 2006, 100:50-76.
55. Waeg G., Dimsity G., Esterbauer H. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic. Res. 1996, 25:149-159.
56. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
57. Watanabe S., Yaginuma R., Ikejima K., Miyazaki A. Liver diseases and metabolic syndrome. J. Gastroenterol. 2008, 43:509-518.
58. Watson C.S., Bulayeva N.N., Wozniak A.L., Finnerty C.C. Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens, and phytoestrogens. Steroids 2005, 70:364-371.
59. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147:S56-S69.
60. Wree A., Kahraman A., Gerken G., Canbay A. Obesity affects the liver - the link between adipocytes and hepatocytes. Digestion 2011, 83:124-133.
61. Zhang Y., Chen F. Reactive oxygen species (ROS), troublemakers between nuclear factor-kappaB (NF-kappaB) and c-Jun NH(2)-terminal kinase (JNK). Cancer Res. 2004, 64:1902-1905.